This is a good buy at current price. $130 seems to be the low water mark. FY16 P/E of 22. Investors are awaiting results from BKL and BAL before they make any moves on these stocks. BKL's infant formula failure is also not helping. A2M made a profit upgrade and is now trading at almost twice the FY16 P/E of BKL.
